The proportion of subjects becoming non-self-sufficient after 12 months of follow-up, defined as those scoring 2 or lower on at least one of the ALSFRS-R items for swallowing, and/or cutting food and/or handling utensils, or walking, in subjects treated with ALCAR 3 g/day and not treated subjects
The 2025 dip likely reflects a combination of maturity and segmentation: fewer new injectable entrants are needed once the market is saturated with credible programs, while attention partially rotates toward oral strategies and next-gen incretin biology
Why Women Plateau More Frequently Women experience more frequent plateaus on GLP-1 medications due to hormonal fluctuations, lower baseline metabolic rates, and greater susceptibility to adaptive thermogenesis
"Omalizumab"
With DSIP, that sentence is unusually blunt: the evidence is genuinely weak and conflicting , the biological activity appears real but the clinical efficacy signal does not, and there are no robust modern human trials to support specific claims for sleep
